REVIEW 3 major objections 4 minor 56 references
Paused in translation: A model for the transcript length-dependent impact of ribosome-targeting antibiotics
T0 review · 3 major / 4 minor · reviewed 2026-08-06 · deepseek-v4-flash
Pith's one-line read Ribosome-targeting antibiotics inhibit longer mRNAs more than short ones, and reducing ribosome initiation offsets the damage.
desk verdict The paper's core length-dependence mechanism is real and the analytics largely hold up, but the Fig. 8 quantitative match rests on an unvalidated mean-field replacement of the random pause time. read the letter →
The pith
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
The reading
What carries the argument
The carrying object is the Single-Cluster Approximation: after the first antibiotic-induced pause at position $X_f$, a single contiguous cluster of ribosomes forms and extends back to the initiation site, then dissolves in discrete batches of average size $B = \frac{k_u}{k_p}[1-(\frac{k_p}{k_p+k_u})^N] + 1$ before any additional distinct cluster appears. This approximation splits the dynamics into two states: an unpaused state obeying standard TASEP with extended particles, and a paused state whose lifetime is $T_p = n_B/k_u$ with $n_B = \lceil N_i/B \rceil$ batches to clear. All analytical expressions for density, current, and the fractions of paused, jammed, and mobile ribosomes follow from the probabilities $P_0$ and $P_p$ of being in each state, making the approximation the bridge from a many-body exclusion process to closed-form formulas.
What would settle it
Watch a single mRNA under fluorophore-tagged ribosomes with chloramphenicol at concentrations where $k_p$ approaches $k_u$: if a second spatially separate ribosome cluster appears before the first one dissolves, or if the measured first-pause time and jam-clearing time deviate from $T_0$ and $T_p$, the central mechanism fails. A population-level test is equally direct: measure fold-change expression of a long and a short reporter driven by identical promoters over a range of antibiotic concentrations and initiation rates; the model's short-to-long ratio must rise with concentration and flatten when initiation is lowered.
Extended reading notes
Core claim
The central discovery is that translation inhibition by elongation-stalling antibiotics is a collective, length-dependent phenomenon. In the model, an antibiotic molecule binds a ribosome at rate $k_p$, pausing it for an average time $1/k_u$ that is long compared with elongation, mRNA lifetime, and initiation intervals. That single paused ribosome blocks all ribosomes behind it, forming one contiguous cluster that reaches back to the initiation site; the jam then dissolves in discrete batches as paused ribosomes unpause. Because longer transcripts hold more ribosomes at steady state, they are hit sooner, their jam takes longer to clear, and their protein output per mRNA drops more steeply with antibiotic concentration. The model's key derived quantities, the unpaused-state lifetime $T_0$, the paused-state lifetime $T_p$, and the density $\rho$ and current $J$ as weighted averages of the two states, reproduce Gillespie simulations and, when mRNA degradation is added, the experimental gfp/lacZ expression ratio under chloramphenicol.
Load-bearing premise
The whole calculation rests on the Single-Cluster Approximation: after the first antibiotic-induced pause, exactly one contiguous jam forms and dissolves completely before any second distinct cluster can appear, an assumption the paper states is valid for slow-binding antibiotics but never quantifies.
Editorial extensions
If this is right
- If correct, chloramphenicol-like antibiotics should reduce protein output per mRNA more for long genes than for short genes even when promoter strength, mRNA abundance, and initiation and elongation rates are identical.
- Lowering ribosome initiation rate should measurably reduce a transcript's antibiotic vulnerability, by lengthening the time to the first pause and shrinking the jam that forms once a pause occurs.
- Estimates of the active-ribosome fraction that count only paused versus non-paused ribosomes overstate protein synthesis under antibiotic stress, because jammed but unpaused ribosomes contribute to density but not to current.
- The short-to-long expression ratio $R$ should rise monotonically with antibiotic concentration, and the model gives a quantitative curve for that rise once initiation rate, mRNA lifetime $\tau$, $k_{\text{on}}$, and $k_u$ are fixed.
- The same two-state pausing-TASEP picture extends to other driven biological traffic with rare, long pauses, notably transcription by RNA polymerases.
Reading between the lines
- The paper's mechanism implies a design principle: cells can buffer long genes against stochastic pausing by lowering their initiation rates, so the observed anticorrelation between gene length and initiation rate in bacteria and yeast may be a consequence of such buffering rather than an unrelated trend.
- Because the first-pause time is set by the collective number of ribosomes on the transcript, reporter-gene comparisons under antibiotics should control for initiation rate as well as length; otherwise differences in ribosome loading would masquerade as length effects.
- A single-molecule translation assay should reveal a bimodal protein-output distribution per mRNA under antibiotic stress: either a near-normal yield if the message degrades before the first pause, or near zero if it is hit, with the fraction of zero-yield transcripts growing with transcript length.
- At high antibiotic binding rates the Single-Cluster Approximation is expected to fail, but the length-dependence should persist; an extension treating coagulation and decoagulation of multiple clusters could sharpen the quantitative predictions precisely in the regime where the analytical formulas start to break down.
Signed reviews
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The paper develops a TASEP model of ribosome translation with stochastic antibiotic-induced pausing and unpausing, and introduces a Single-Cluster Approximation in which the first pause creates a single contiguous jam that fills back to the initiation site and dissolves in discrete batches. The authors derive analytical expressions for the unpaused-state lifetime, first-pause position, paused-state lifetime, density, current, particle state fractions, and hitting probability, and validate these against Gillespie simulations. They then extend the model to include finite mRNA lifetimes and use it to predict the short-to-long expression ratio for gfp and lacZ under chloramphenicol, reporting quantitative agreement with the experimental data of Zhang et al. (Fig. 8). The central claims are that antibiotic-induced inhibition is strongly transcript-length dependent, that lowering initiation rates mitigates vulnerability, and that collective ribosome dynamics, rather than single-ribosome properties, govern the response.
Significance. If the results hold, this is a valuable contribution to the modeling of translation under antibiotic stress. The paper's strengths are its explicit analytical treatment, the use of experimentally measured pausing/unpausing rates, and the systematic Gillespie validation of the core observables (lifetimes, densities, currents, and fractions) in Figs. 2-7. The length-dependence prediction and the initiation-rate mitigation effect are concrete and falsifiable, and the model gives a mechanistic explanation for why longer transcripts are more vulnerable. The comparison with Zhang et al. is an ambitious step toward quantitative validation, but it is the least secure part of the paper because it relies on an unvalidated mean-field replacement and on fitted parameters whose number is reported inconsistently. The core modeling framework is nevertheless defensible and the analytical results for the pre-validation part are credible.
major comments (3)
- The protein-output formula replaces the random first-pause time by its mean T0. The actual first-pause time has the broad distribution F(t) in Eq. (11), and mRNA degradation is exponential with density in Eq. (33); the correct expected output is an integral over the stopping time min(T_pause, T_degradation), not an evaluation at the mean T0. This mean replacement is never validated against Gillespie simulations, and it creates a hard cutoff: Eq. (38) sets P=0 whenever T0 <= tL. For lacZ at high chloramphenicol concentrations, e.g. kp ~ 0.027 s^-1 with the parameters in Fig. 8, one obtains T0 ~ 23 s while tL ~ 51 s, so Eq. (38) predicts zero lacZ output even though stochastic realizations with first-pause times beyond tL, and ribosomes that have already passed the pause site, would still produce finite protein. This could artificially steepen the short-to-long ratio R and create the appearance of quantitative agreement. This is the load-bearing step for the central validation claim, so it must be corrected by integrating over F(t) and the mRNA lifetime distribution, or otherwise rigorously justified against simulations, and the impact on Fig. 8 must be reassessed.
- The validity conditions of the Single-Cluster Approximation are stated only qualitatively: kp << epsilon, beta ~ epsilon, and 'the segment cannot be too long'. The approximation is used in Fig. 8 at antibiotic concentrations where kp is not small compared to ku; for example, at 10 uM chloramphenicol kp ~ 5.4e-3 s^-1 and ku = 1.4e-3 s^-1, so the batch size B = ku/kp + 1 is about 1.26, meaning the 'clusters' are small and multiple pauses can occur before a cluster dissolves. The authors should quantify the regime of validity, ideally with a phase diagram or simulation-based boundary, and demonstrate that the experimental comparison in Fig. 8 lies inside that regime. Without this, the analytical formulas for Tp, density, and current, and therefore the protein-output prediction, are not guaranteed to apply in the very regime used for the quantitative claim.
- The number of fitted parameters in the experimental comparison is reported inconsistently. The Fig. 8 caption states that a fitted initiation rate alpha = 0.12 s^-1 and a mean mRNA lifetime tau = 170 s are used, while the Discussion states that the model 'quantitatively reproduces experimental differences ... by fitting only the degradation time tau'. This discrepancy matters because the 'quantitative agreement' is not parameter-free: it depends on two biologically plausible but adjustable parameters, and no confidence intervals, sensitivity analysis, or goodness-of-fit measure is reported. The authors should clarify which parameters were fitted, show how the fit was performed, and report the sensitivity of the short-to-long ratio R to alpha and tau, especially given the hard cutoff issue in Eq. (38).
minor comments (4)
- The quantity tL is defined in Eq. (5) as the domain-wall traversal time L/(epsilon-alpha), but in Sec. IV B it is called 'the time required for a ribosome to translate the full mRNA', which for a single ribosome should be L/epsilon. This notational reuse should be clarified, since the comparison with the single-ribosome hitting probability relies on the same symbol.
- The binding rate constant kon is given as 5.6 x 10^-4 uM^-1 s^-1 in the text and 5.4 x 10^-4 uM^-1 s^-1 in the Fig. 8 caption. Please reconcile the values and cite the corresponding uncertainty.
- Some figure labels appear truncated or orphaned: Fig. 4 contains a floating heading 'Paused-state fraction,' and the legend entries in Fig. 6 are cut off ('(mobile+jammed)' and 'this work (mobile)'). The figures should be readable without referring to the main text.
- The text has a minor typo ('mRNAS' for 'mRNAs'), and the notation P(t) for protein number is easily confused with the probability P0 and Pp from Eq. (21). A different symbol or a brief reminder would improve readability.
Circularity Check
The analytical derivation is self-contained; the only circularity-adjacent step is the 'quantitative match' to Zhang et al., which uses two parameters fitted to that same dataset rather than an independent prediction.
-
fitted input called prediction
[Sec. IV C, Eq. (38)-(39), Fig. 8 caption; Discussion (Sec. V)]
"The parameters used are kon = 5.4 × 10−4 µM−1s−1, ku = 1.4 × 10−3 s−1 (giving KD ≈ 2.5 µM), with a fitted initiation rate of 0.12 s−1 and a mean mRNA lifetime τ = 170 s. ... The predictions from our model quantitatively match the experimental data, as shown in Fig. 8."
The claimed quantitative agreement with the experimental short-to-long expression ratio R is not an independent prediction: the two free parameters entering Eq. (38) (the initiation rate α and the mRNA lifetime τ) are fitted to the same Zhang et al. dataset that R is then said to match. The curve in Fig. 8 is therefore calibrated, not predicted, and the Discussion's statement that the model reproduces the data 'by fitting only the degradation time τ' omits the separately fitted initiation rate, understating the degrees of freedom. The qualitative length-dependence is still derived from the model's assumptions, so this is partial circularity in the validation step rather than in the core derivation.
full rationale
The core model derivation is not circular: the length-dependence follows from the stated per-ribosome independent pausing hazard λ(t)=kpN(t) and the finite-lattice filling dynamics, and the Single-Cluster Approximation is an explicit assumption tested against Gillespie simulations, not a conclusion smuggled in through self-citation. The analytical expressions for density, current, hitting probability, and protein output are derived from the model equations; the reported agreement with simulations supports the internal consistency of the derivation. No load-bearing uniqueness theorem or ansatz is imported from the authors' prior work; the self-citation [30] is used only for a mapping remark and is not needed for the central claims. The only circularity-adjacent element is the experimental validation: the 'quantitative match' in Fig. 8 is obtained after fitting both α and τ to the same dataset, and the text sometimes presents this as prediction. This does not invalidate the model's qualitative predictions, but it means the quantitative agreement is partly constructed by the fit rather than being an out-of-sample test.
Assumptions & free parameters
free parameters (3)
- alpha (ribosome initiation rate) =
0.12 s^-1
- tau (mean mRNA lifetime) =
170 s
- transcriptional efficiency threshold (Appendix C) =
approximately 0.95 fraction of time in unpaused state
assumptions (5)
- standard math Standard TASEP mean-field expressions for extended particles, J0 = alpha(epsilon - alpha)/(epsilon + alpha(ell - 1)) and rho0 = alpha/(epsilon + alpha(ell - 1)), are valid (Eq. 6).
- domain assumption mRNA lifetime is exponentially distributed with mean tau (Eq. 33).
- domain assumption Once a ribosome pauses, the mRNA is degraded before the antibiotic unbinds, so no further protein is produced after the first pause (Sec. IV C).
- ad hoc to paper Single-Cluster Approximation: after the first pause, a single contiguous jam fills back to the initiation site and dissolves in batches of size B, with no second distinct cluster forming (Sec. II B).
- domain assumption Termination is fast relative to other translation events, effectively beta approximately epsilon (condition ii in Sec. II B).
Cite this review
Pith. "Pith review of Paused in translation: A model for the transcript length-dependent impact of ribosome-targeting antibiotics." pith.science (2026). https://pith.science/paper/AVUWU444
@misc{pith2026250719395,
author = {Pith},
title = {Pith review of: Paused in translation: A model for the transcript length-dependent impact of ribosome-targeting antibiotics},
year = {2026},
howpublished = {\url{https://pith.science/paper/AVUWU444}},
note = {Machine review of arXiv:2507.19395}
}
read the original abstract
Ribosome-targeting antibiotics, such as chloramphenicol, stall elongating ribosomes during protein synthesis, disrupting mRNA translation. These antibiotic-induced pauses occur stochastically, alter collective ribosome dynamics and transiently block protein production on the affected transcript. Existing models of ribosome traffic often rely on idealized assumptions, such as infinitely long mRNAs and simplified pausing dynamics, overlooking key biological constraints. Here, we develop a Totally Asymmetric Simple Exclusion Process (TASEP) that incorporates stochastic particle pausing, using experimentally determined pausing and unpausing rates to model the effects of ribosome-targeting antibiotics. We introduce a Single-Cluster approximation, which is analytically treatable, tailored to capture the biologically relevant regime of rare and long antibiotic-induced pauses. This biologically constrained model reveals three key insights: (i) the inhibition of antibiotic-induced translation strongly depends on transcript length, with longer transcripts being disproportionately affected; (ii) reducing ribosome initiation rates significantly mitigates antibiotic vulnerability; and (iii) inhibition of translation is governed more by collective ribosome dynamics than by single-ribosome properties. Our analytical predictions match Gillespie simulations, align quantitatively with experimental observations, and yield testable hypotheses for future experiments. These findings may have broader implications for the mechanistic modeling of other biological transport processes (e.g., RNAP dynamics), and more generally for the community studying traffic models.
Figures
Figures from the paper (6 more)
Reference graph
Works this paper leans on
-
[1]
Particles pause independently following a stochastic Poisson process with rate kp
Lifetime Distribution of the Unpaused State The random time T0 until the first pausing event can be analysed by viewing pauses as a simple point process, in which times at which pauses occur form a random set of points on the time axis. Particles pause independently following a stochastic Poisson process with rate kp. How- ever, the number of particles in...
-
[2]
Expected Lifetime of the Unpaused State The expected duration of the unpaused state, denoted as T0, now follows as the average time when the first pausing event occurs, thus using the function F (t) in Eq. (11) to weight the average: T0 = Z tL 0 t F(t) dt Note that F (t) is the probability density function for the distribution of the first pausing time. S...
-
[3]
Entering the paused state and expected first pausing position In order to quantify the length of the jam in the paused state we must identify the position at which the first pausing event occurs. To this end we first consider the instantaneous position of the domain wall, xs(t), as de- fined in Eq. (4). Any particle behind this domain wall has an equal pr...
-
[4]
Lifetime of the paused state To compute the lifetime of the paused state we need to evaluate the time to dissolve it by successive release of discrete batches of particles (see Fig. 1). The number of particles in the initial cluster is, on average, Ni := Xf /ℓ when considering the filling of the initial cluster as a fast process. This means that the loadi...
-
[5]
Particle density The total particle density, ρ, is obtained as a weighted average of the paused and unpaused states, ρ = P0ρ0 + Ppρp, (22) where the probabilities P0 and Pp are defined in Eq. (21), and the steady-state density in the unpaused state ρ0 is given by the standard TASEP expression, Eq. (6). To analytically determine the density in the paused s...
-
[6]
Current Similarly to the density, we can also compute the av- erage current, J, as a weighted sum: J = P0 J0 + Pp Jp. (26) 8 The contribution from the unpaused state is given simply by the zero-paused particle current J0, as described by the standard TASEP expression for extended particles, Eq. (6). Conversely, the current contribution Jp from the paused ...
-
[7]
Microscopic particle states Having characterized the global properties of the sys- tem in terms of density and current, we now turn our attention to the microscopic dynamics by categorizing the states of individual particles. In order to do that, we divide particles in three distinct categories: paused, mobile, and jammed (not paused, but blocked by exclu...
-
[8]
S. Klumpp and T. Hwa 105, 10.1073/pnas.0806084105
Show all 56 references
- [9]
-
[10]
C. T. MacDonald, J. H. Gibbs, and A. C. Pipkin, Biopolymers 6, 1 (1968)
1968
-
[11]
R. A. Blythe and M. R. Evans, Journal of Physics A: Mathematical and Theoretical 40, 10.1088/1751- 8113/40/46/R01 (2007)
2007 doi
-
[12]
Tripathi and D
T. Tripathi and D. Chowdhury, Phys. Rev. E 77, 011921 (2008)
2008
-
[13]
J. Wang, B. Pfeuty, Q. Thommen, M. C. Romano, and M. Lefranc 90, 10.1103/PhysRevE.90.050701
-
[14]
A. A. van den Berg and M. Depken, Nucleic Acids Re- search 45, 7623 (2017)
2017
-
[15]
R. C. Mines, T. Lipniacki, and X. Shen, PLOS Compu- tational Biology 18, 1 (2022)
2022
-
[16]
L. B. Shaw, R. K. P. Zia, and K. H. Lee, Physical Review E 68, 021910 (2003)
2003
-
[17]
Klumpp, Y
S. Klumpp, Y. Chai, and R. Lipowsky, Physical Review E 78, 041909 (2008)
2008
-
[18]
Ciandrini, I
L. Ciandrini, I. Stansfield, and M. C. Romano, Physical Review E 81, 051904 (2010)
2010
-
[19]
Rousset, L
Y. Rousset, L. Ciandrini, and N. Kern, SciPost Phys. 6, 077 (2019)
2019
-
[20]
L. B. Shaw, J. P. Sethna, and K. H. Lee, Physical Review E—Statistical, Nonlinear, and Soft Matter Physics 70, 021901 (2004)
2004
-
[21]
Szavits-Nossan, L
J. Szavits-Nossan, L. Ciandrini, and M. C. Romano, Phys. Rev. Lett. 120, 128101 (2018)
2018
-
[22]
D. D. Erdmann-Pham, K. D. Duc, and Y. S. Song, Cell systems 10, 183 (2020)
2020
-
[23]
Ciandrini, R
L. Ciandrini, R. L. Crisostomo, and J. Szavits-Nossan, SciPost Physics Codebases , 022 (2023)
2023
-
[24]
Turci, A
F. Turci, A. Parmeggiani, E. Pitard, M. C. Romano, and L. Ciandrini, Physical Review E 87, 012705 (2013)
2013
-
[25]
Waclaw, J
B. Waclaw, J. Cholewa-Waclaw, and P. Greulich, 52
-
[26]
C. Zhu, X. Guo, P. Dumas, M. Takacs, M. Abdelkareem, A. Vanden Broeck, C. Saint-Andr´ e, G. Papai, C. Crucifix, J. Ortiz, and A. Weixlbaumer, Nature Communications 13, 1546 (2022)
2022
-
[27]
Zhang, E
Q. Zhang, E. Brambilla, R. Li, H. Shi, M. Cosentino Lagomarsino, and B. Sclavi, mSystems 5, 10.1128/mSystems.00575-20 (2020)
2020 doi
-
[28]
C. T. Walsh, Protein Science 13, 3059 (2004)
2004
-
[29]
R. J. Harvey and A. L. Koch 18, 10.1016/0022- 2836(74)90234-4
-
[30]
Chopra and T
I. Chopra and T. G. Howe, Microbiological Reviews 42, 707 (1978)
1978
-
[31]
Berens, A
C. Berens, A. Thain, and R. Schroeder, Bioorganic & Medicinal Chemistry 9, 2549 (2001)
2001
-
[32]
Pestka, Antimicrobial Agents and Chemotherapy 6, 474 (1974)
S. Pestka, Antimicrobial Agents and Chemotherapy 6, 474 (1974)
1974
-
[33]
X. Dai, M. Zhu, M. Warren, R. Balakrishnan, V. Patsalo, H. Okano, J. R. Williamson, K. Fredrick, Y.-P. Wang, and T. Hwa 2, 10.1038/nmicrobiol.2016.231
2016 doi
-
[34]
Ciandrini, I
L. Ciandrini, I. Stansfield, and M. C. Romano, PLoS Comput. Biol. 9, e1002866 (2013)
2013
-
[35]
Milo and R
R. Milo and R. Phillips, Cell Biology by the Numbers (Garland Science, New York, 2015)
2015
-
[36]
Balakrishnan, M
R. Balakrishnan, M. Mori, I. Segota, Z. Zhang, R. Ae- bersold, C. Ludwig, and T. Hwa, Science 378, eabk2066 (2022)
2022
-
[37]
Keisers, L
J. Keisers, L. V. Dal Zovo, N. Kern, and L. Ciandrini, Biologically relevant finite-size effects in a driven lattice gas with particle pausing and dynamical defects (2024), arXiv:2406.16569 [cond-mat.stat-mech]
2024 arXiv
-
[38]
A. B. Kolomeisky, G. M. Sch¨ utz, E. B. Kolomeisky, and J. P. Straley, Journal of Physics A: Mathematical and General 31, 6911 (1998)
1998
-
[39]
Santen and C
L. Santen and C. Appert, Journal of statistical physics 106, 187 (2002)
2002
-
[40]
Cividini, H
J. Cividini, H. J. Hilhorst, and C. Appert-Rolland, Jour- nal of Physics A: Mathematical and Theoretical 47, 222001 (2014)
2014
-
[41]
Szavits-Nossan and M
J. Szavits-Nossan and M. R. Evans, Physical Review E 101, 10.1103/PhysRevE.101.062404 (2020)
2020 doi
-
[42]
J. F. C. Kingman, Poisson Processes (Oxford University Press, Oxford, UK, 1993)
1993
-
[43]
S. M. Ross, Stochastic Processes, 2nd ed., Wiley Series in Probability and Statistics (John Wiley & Sons, New York, 1996)
1996
-
[44]
C. Wu, R. Balakrishnan, N. Braniff, M. Mori, G. Man- 15 zanarez, Z. Zhang, and T. Hwa, Proceedings of the Na- tional Academy of Sciences 119, e2201585119 (2022)
2022
-
[45]
Keisers and J
J. Keisers and J. Krug, Journal of Physics A: Mathemat- ical and Theoretical 56, 385601 (2023)
2023
-
[46]
Ikeuchi, T
K. Ikeuchi, T. Izawa, and T. Inada, Frontiers in Genetics 9, 10.3389/fgene.2018.00743 (2019)
2019
-
[47]
A. R. Subramaniam, B. M. Zid, and E. K. O’Shea, Cell 159, 1200 (2014)
2014
-
[48]
L. D. Fernandes, A. P. de Moura, and L. Ciandrini, Sci- entific Reports 7, 17409 (2017)
2017
-
[49]
Scott, E
M. Scott, E. M. Mateescu, Z. Zhang, and T. Hwa, Science 330, 1099 (2010)
2010
-
[50]
Uemura, C
S. Uemura, C. E. Aitken, J. Korlach, B. A. Flusberg, S. W. Turner, and J. D. Puglisi, Nature464, 1012 (2010)
2010
-
[51]
K. C. Neuman, E. A. Abbondanzieri, R. Landick, J. Gelles, and S. M. Block, Cell 115, 437 (2003)
2003
-
[52]
Janissen, B
R. Janissen, B. Eslami-Mossallam, I. Artsimovitch, M. Depken, and N. H. Dekker, Cell Reports 39, 10.1016/j.celrep.2022.110749 (2022)
2022
-
[53]
M. H. Moreira, G. C. Barros, R. D. Requi˜ ao, S. Rossetto, T. Domitrovic, and F. L. Palhano, RNA Biology16, 1806 (2019)
2019
-
[54]
P. Shah, Y. Ding, M. Niemczyk, G. Kudla, and J. B. Plotkin, Cell 153, 1589 (2013)
2013
-
[55]
Greulich, L
P. Greulich, L. Ciandrini, R. J. Allen, and M. C. Romano, Physical Review E 85 (2012)
2012
-
[56]
D. T. Gillespie, Journal of computational physics 22, 403 (1976)
1976
Reviewed August 6, 2026 · model on record in the stance chip above.
Discussion (0). Continue with ORCID to comment.